MBX Biosciences, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
MBX Biosciences, Inc. quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q3 2023 to Q3 2024.
  • MBX Biosciences, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2024 was -$18M, a 77.5% decline year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$18M -$7.87M -77.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q3 2023 -$10.2M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.